Clinical trial
Expression of the JAK-STAT Signaling Pathway in Pyoderma Gangrenosum Pathological Biopsy
NCT04792957 is registered in ClinicalTrials.gov with Dokuz Eylul University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Expression of the JAK-STAT Signaling Pathway in Pyoderma Gangrenosum Pathological Biopsy
- Lead sponsor
- Dokuz Eylul University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2022
- Completion date
- July 31, 2022
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.